Skip to main content

Table 1 Characteristics of 164 elderly patients with hip fracture

From: Intervention to improve the appropriate use of polypharmacy for older patients with hip fractures: an observational study

Characteristics

Intervention

N = 32

Usual care

N = 132

P-value

Patient characteristics

 Age, mean ± SD

83.8 ± 6.2

85.1 ± 6.7

0.28

 Men, n (%)

7 (21.9)

28 (21.2)

1.00

 Institutional resident, n (%)

7 (21.9)

47 (35.6)

0.15

CCI, mean ± SD

2.7 ± 1.6

2.0 ± 1.8

0.04

Number of medications at admission

 Total, mean ± SD

9.2 ± 2.5

7.8 ± 2.5

0.01

 5–8 medications, n (%)

15 (46.9)

88 (66.7)

0.04

 9–12 medications, n (%)

13 (40.6)

38 (28.8)

0.21

 13 or more medications, n (%)

4 (12.5)

6 (4.5)

0.11

Number of medications at discharge

 Total, mean ± SD

4.5 ± 2.6

6.8 ± 2.4

< 0.001

 0–4 medications, n (%)

18 (56.3)

21 (15.9)

< 0.001

 5–8 medications, n (%)

13 (40.6)

85 (64.4)

0.02

 9–12 medications, n (%)

0 (0.0)

23 (17.4)

0.02

 13 or more medications, n (%)

1 (3.1)

3 (2.3)

1.00

Fall-risk-increasing drugsa at admission

 Total number, mean ± SD

2.9 ± 1.3

2.6 ± 1.4

0.22

 0–2 medications, n (%)

13 (40.6)

62 (47.0)

0.56

 3–5 medications, n (%)

16 (50.0)

65 (49.2)

1.00

 6 or more medications, n (%)

1 (3.1)

5 (3.8)

1.00

Fall-risk-increasing drugsa at discharge

 Total number, mean ± SD

1.4 ± 1.2

2.1 ± 1.4

0.01

 0–2 medications, n (%)

27 (84.4)

80 (60.6)

0.01

 3–5 medications, n (%)

5 (15.6)

50 (37.9)

0.02

 6 or more medications, n (%)

0 (0.0)

2 (1.5)

1.00

PIMsb at admission

 Total number, mean ± SD

1.5 ± 0.8

1.3 ± 1.1

0.19

 0–1 medication, n (%)

17 (53.1)

83 (62.9)

0.32

 2–3 medications, n (%)

15 (46.9)

44 (33.3)

0.22

 4 or more medications, n (%)

0 (0.0)

5 (3.8)

0.58

PIMsb at discharge

 Total number, mean ± SD

0.8 ± 0.8

1.1 ± 1.0

0.03

 0–1 medication, n (%)

27 (84.4)

89 (67.4)

0.08

 2–3 medications, n (%)

5 (15.6)

41 (31.1)

0.12

 4 or more medications, n (%)

0 (0.0)

2 (1.5)

1.00

Past medical history, n (%)

 Dementia

14 (43.8)

55 (41.7)

0.84

 Heart diseasec

5 (15.6)

28 (21.2)

0.63

 Stroke

11 (34.4)

28 (21.2)

0.16

 Diabetes mellitus

6 (18.6)

35 (26.5)

0.50

 Hip fracture

2 (6.3)

19 (14.4)

0.37

 Any fracture

14 (43.8)

44 (33.3)

0.31

 Current smoker, n (%)

1 (3.1)

11 (8.3)

0.46

 Current drinker, n (%)

3 (9.4)

10 (7.6)

0.72

Type of hip fracture, n (%)

 Intracapsular fracture

17 (53.1)

60 (45.5)

0.55

 Intertrochanteric fracture

11 (36.7)

67 (50.8)

0.12

 Subtrochanteric fracture

4 (12.5)

4 (3.0)

0.05

 Others

0 (0.0)

1 (0.8)

1.00

Management during admission

 Surgery, n (%)

31 (96.9)

129 (97.7)

0.58

 VTE prophylaxis, n (%)

32 (100)

130 (98.5)

1.00

 Perioperative antibiotics, n (%)

31 (100)

129 (100)

1.00

 Medical consultationd, n (%)

7 (21.9)

41 (31.7)

0.39

Osteoporosis treatment, n (%)

 PTH analogue

2 (6.3)

2 (1.5)

0.17

 Bisphosphonate

3 (9.4)

6 (4.5)

0.38

 Vitamin D

3 (9.4)

21 (15.9)

0.42

  1. aFall-risk-increasing drugs included antihypertensives, alpha-adrenoreceptor antagonists, opioids, dopaminergic agents, antipsychotics, anxiolytics, hypnotics and antidepressants
  2. bPIMs were defined based on the 2015 American Geriatric Society Beers Criteria
  3. cHeart disease included angina, myocardial infarction and heart failure
  4. dThis category included consultation about medical problems other than polypharmacy